Atara Biotherapeutics Inc
NASDAQ:ATRA
Atara Biotherapeutics Inc
NASDAQ:ATRA
Price:
0.71 USD
16.39%
Market Closed
Updated:
May 21, 2024
Atara Biotherapeutics Inc
Short-Term Investments
|
Atara Biotherapeutics Inc
Short-Term Investments Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Short-Term Investments Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Short-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
Short-Term Investments
$11.2m
|
CAGR 3-Years
-66%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Short-Term Investments
$2m
|
CAGR 3-Years
-55%
|
CAGR 5-Years
-64%
|
CAGR 10-Years
-46%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Short-Term Investments
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Short-Term Investments
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Short-Term Investments
$1B
|
CAGR 3-Years
18%
|
CAGR 5-Years
12%
|
CAGR 10-Years
1%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Short-Term Investments
$7.9B
|
CAGR 3-Years
56%
|
CAGR 5-Years
39%
|
CAGR 10-Years
46%
|
See Also
What is Atara Biotherapeutics Inc's Short-Term Investments?
Short-Term Investments
11.2m
USD
11.2m
USD
Based on the financial report for Mar 31, 2024, Atara Biotherapeutics Inc's Short-Term Investments amounts to 11.2m USD.
What is Atara Biotherapeutics Inc's Short-Term Investments growth rate?
Short-Term Investments CAGR 5Y
-43%
-43%
Over the last year, the Short-Term Investments growth was -93%. The average annual Short-Term Investments growth rates for Atara Biotherapeutics Inc have been -66% over the past three years , -43% over the past five years .
You don't have any saved screeners yet
